An Open-label, Multicenter Study of the Pharmacokinetics, Efficacy and Safety of Olokizumab in Pediatric and Adolescent Patients With Active Juvenile Idiopathic Arthritis
NCT07517575 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by R Pharm International Llc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by R Pharm International Llc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
R Pharm International Llc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
R Pharm International Llc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, R Pharm International Llc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.